{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:25:56Z","timestamp":1772688356230,"version":"3.50.1"},"reference-count":20,"publisher":"Academy of Managed Care Pharmacy","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMCP"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.18553\/jmcp.2025.25264","type":"journal-article","created":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T09:49:36Z","timestamp":1766224176000},"page":"312-322","source":"Crossref","is-referenced-by-count":0,"title":["Infusion therapy patient outcomes are similar at reduced costs in alternative sites of care compared with hospital outpatient departments: A matched cohort analysis of infusion therapy across multiple chronic conditions"],"prefix":"10.18553","volume":"32","author":[{"given":"Daniel","family":"Cullen","sequence":"first","affiliation":[{"name":"Elevance Health Public Policy Institute, Indianapolis, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliza S.","family":"Gordon","sequence":"additional","affiliation":[{"name":"Elevance Health Public Policy Institute, Indianapolis, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Adkins Svoboda","sequence":"additional","affiliation":[{"name":"Elevance Health Public Policy Institute, Indianapolis, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madison","family":"Alvarez","sequence":"additional","affiliation":[{"name":"Elevance Health Public Policy Institute, Indianapolis, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Cobb","sequence":"additional","affiliation":[{"name":"Elevance Health Public Policy Institute, Indianapolis, IN"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7818","reference":[{"key":"r1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.5544"},{"key":"r2","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2016.012930"},{"issue":"12","key":"r3","first-page":"4525","volume":"27","author":"Mahendraratnam N","year":"2019","journal-title":"Support Care Cancer"},{"key":"r4","doi-asserted-by":"publisher","DOI":"10.1002\/hec.4909"},{"key":"r5","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2023.2194185"},{"key":"r6","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-017-0371-0"},{"key":"r7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.10268"},{"key":"r8","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51745"},{"key":"r9","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S121032"},{"key":"r10","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz471"},{"key":"r11","unstructured":"Carelon Research.\n                      Carelon Research\u2019s Healthcare Integrated Research Database (HIRD).\n                      Carelon Research; 2024. Accessed July 2, 2025. https:\/\/www.carelonresearch.com\/content\/dam\/digital\/carelon\/pdf\/Carelon_Research_HIRD_technical_white_paper_March_2024_fv.pdf"},{"key":"r12","unstructured":"American Academy of Allergy, Asthma, and Immunology. Guidelines for the site of care for administration of IGIV therapy. 2011. Accessed July 2, 2025. https:\/\/www.aaaai.org\/Aaaai\/media\/Media-Library-PDFs\/Practice%20Management\/Practice%20Tools\/Guidelines-for-the-site-of-care-for-administration-of-IGIV-therapy.pdf"},{"key":"r13","unstructured":"CarelonRx. Managing inflammatory conditions and specialty drug trend. 2023. Accessed July 2, 2025. https:\/\/www.carelonrx.com\/perspectives\/inflammatory-conditions-specialty-drug-trend"},{"key":"r14","unstructured":"International RTI.\n                      Creation of New Race-Ethnicity Codes and Socioeconomic Status (SES) Indicators for Medicare Beneficiaries\n                      . Agency for Healthcare Research and Quality; 2008. Accessed July 2, 2025. https:\/\/citeseerx.ist.psu.edu\/document?repid=rep1&type=pdf&doi=abd8d0c761bc4f0fcf9593727e93ef8c04cf1c0e"},{"key":"r15","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000182534.19832.83"},{"issue":"9","key":"r16","first-page":"494","volume":"8","author":"Tkacz J","year":"2015","journal-title":"Am Health Drug Benefits"},{"key":"r17","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2017.1384736"},{"key":"r18","unstructured":"Aetna. Drug infusion\/Injection site of care policy. Accessed November 11, 2025. https:\/\/www.aetna.com\/health-care-professionals\/utilization-management\/drug-infusion-site-of-care-policy.html"},{"key":"r19","unstructured":"UnitedHealthcare. Provider administered drugs \u2013 site of care. UnitedHealthcare Commercial Medical Benefit Drug Policy. 2025. Accessed November 11, 2025. https:\/\/www.uhcprovider.com\/content\/dam\/provider\/docs\/public\/policies\/comm-medical-drug\/provider-administered-drugs-soc.pdf"},{"key":"r20","unstructured":"Cigna Healthcare. Medication administration site of care. Drug coverage policy. 2024. Accessed November 11, 2025. https:\/\/static.cigna.com\/assets\/chcp\/pdf\/coveragePolicies\/pharmacy\/ph_1605_coveragepositioncriteria_site_of_care.pdf"}],"container-title":["Journal of Managed Care & Specialty Pharmacy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T03:24:36Z","timestamp":1772681076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jmcp.org\/doi\/10.18553\/jmcp.2025.25264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.18553\/jmcp.2025.25264"],"URL":"https:\/\/doi.org\/10.18553\/jmcp.2025.25264","relation":{},"ISSN":["2376-0540","2376-1032"],"issn-type":[{"value":"2376-0540","type":"print"},{"value":"2376-1032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3]]}}}